Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin

被引：0
|
作者：
Belle, Ludovic [1 ]
Binsfeld, Marilene [1 ]
Dubois, Sophie [1 ]
Hannon, Muriel [1 ]
Caers, Jo [1 ]
Briquet, Alexandra [1 ]
Menten, Catherine [1 ]
Beguin, Yves [1 ]
Humblet, Stephanie [1 ]
Baron, Frederic [1 ]
机构：
[1] Univ Liege, GIGA 13, Liege, Belgium
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2012.11.476
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
418
引用
收藏
页码：S317 / S318
页数：2
相关论文
共 50 条
  • [31] Inhibition of p38 MAP kinase suppresses murine Sclerodermatous Chronic Graft-Versus-Host Disease
    Matsushita, T.
    Date, M.
    Hamaguchi, Y.
    Hasegawa, M.
    Fujimoto, M.
    Takehara, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S245 - S245
  • [32] Effective prevention of murine graft-versus-host disease by rapamycin is associated with the appearance of suppressor cells.
    Chen, J
    Morris, RE
    Chao, NJ
    BLOOD, 1996, 88 (10) : 982 - 982
  • [33] TREATMENT OF REFRACTORY SCLERODERMATOUS GRAFT-VERSUS-HOST DISEASE WITH ETRETINATE
    MARCELLUS, DC
    FREEMER, CS
    FARMER, EB
    ALTOMONTE, V
    VOGELSANG, GB
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1106 - 1106
  • [34] Kinetics of circulating endothelial progenitors in patients with sclerodermatous chronic graft-versus-host disease
    Ahihara, Eishi
    Shimura, Kazuho
    Shimazaki, Chihiro
    Matsunaga, Shinsaku
    Tanaka, Ruriko
    Yokota, Asumi
    Murotani, Yoshihide
    Takeuchi, Miki
    Kawata, Eri
    Kamitsuji, Yuri
    Kuroda, Junya
    Taniwaki, Masafumi
    Kimura, Shinya
    Maekawa, Taira
    BLOOD, 2007, 110 (11) : 326A - 327A
  • [35] Blockade of Syk Ameliorates the Development of Sclerodermatous Chronic Graft-Versus-Host Disease.
    Matsushita, T.
    Le Huu, D.
    Kimura, H.
    Date, M.
    Hamaguchi, Y.
    Hasegawa, M.
    Fujimoto, M.
    Takehara, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S3 - S3
  • [36] Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions
    Phipps, C.
    Lupo-Stanghellini, M. T.
    Flowers, M. E. D.
    BONE MARROW TRANSPLANTATION, 2014, 49 (02) : 315 - 316
  • [37] Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease
    M Okamoto
    A Okano
    S Akamatsu
    E Ashihara
    T Inaba
    H Takenaka
    N Katoh
    S Kishimoto
    C Shimazaki
    Leukemia, 2006, 20 : 172 - 173
  • [38] Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions
    C Phipps
    M T Lupo-Stanghellini
    M E D Flowers
    Bone Marrow Transplantation, 2014, 49 : 315 - 316
  • [39] Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease
    Okamoto, M
    Okano, A
    Akamatsu, S
    Ashihara, E
    Inaba, T
    Takenaka, H
    Katoh, N
    Kishimoto, S
    Shimazaki, C
    LEUKEMIA, 2006, 20 (01) : 172 - 173
  • [40] Efficacy of Imatinib Mesylate in the Treatment of Refractory Sclerodermatous Chronic Graft-Versus-Host Disease
    Yakoub-Agha, Ibrahim
    Magro, Leonardo
    Catteau, Benoit
    Willekens, Christophe
    Coiteux, Valerie
    Bruno, Benedicte
    Terriou, Louis
    Jouet, Jean-Pierre
    BLOOD, 2008, 112 (11) : 745 - 746
12345